Thomas S. Lam - Feb 15, 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Thomas S. Lam
Stock symbol
ASTH
Transactions as of
Feb 15, 2025
Transactions value $
$0
Form type
4
Date filed
2/18/2025, 09:50 PM
Previous filing
Nov 12, 2024
Next filing
Mar 7, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Other $0 -700K -10.24% $0.00 6.13M Feb 15, 2025 By Allied Physicians of California, a Professional Medical Corporation F1, F2
transaction ASTH Common Stock Other $0 +26.2K +2.37% $0.00 1.13M Feb 15, 2025 By the Thomas and Jeanette Lam 2002 Family Trust F3
holding ASTH Common Stock 439K Feb 15, 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation ("APC"), of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 APC distributed these shares of the Issuer's common stock to its stockholders, pursuant to a pro rata distribution for no consideration. Includes 17,839 shares in the aggregate held for the benefit of disqualified shareholders of APC.
F3 Represents the receipt of shares of the Issuer's common stock pursuant to the pro rata distribution for no consideration by APC, of which the Reporting Person is a stockholder.
F4 Includes 130,000 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 43,333 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; and (ii) grants of 30,000 shares, 30,000 shares and 26,667 shares, each of which will vest upon achievement of certain pre-established performance goals.